Finance

Lists
4967:TYO
Kobayashi Pharmaceutical Co Ltd
7 107,00 JPY
+1,69%
(+118,00) 1D
2 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
6 988 JPY
High
7 222 JPY
Low
6 933 JPY
Mkt. cap
554,70 მლრ.
Avg. vol.
278,34 ათ.
Volume
580,80 ათ.
Dividend
1,48%
Quarterly dividend
26 JPY
Ex-dividend date
29 დეკ. 2026
P/E ratio
325,12
52-wk high
7 222 JPY
52-wk low
5 030 JPY
EPS
22 JPY
Shares outstanding
79,07 მლნ.
No. of employees
4 ათ.
Open
6 988 JPY
High
7 222 JPY
Low
6 933 JPY
Mkt. cap
554,70 მლრ.
Avg. vol.
278,34 ათ.
Volume
580,80 ათ.
Dividend
1,48%
Quarterly dividend
26 JPY
Ex-dividend date
29 დეკ. 2026
P/E ratio
325,12
52-wk high
7 222 JPY
52-wk low
5 030 JPY
EPS
22 JPY
Shares outstanding
79,07 მლნ.
No. of employees
4 ათ.
News stories
From web sources and news partners
About Kobayashi Pharmaceutical Co Ltd
CEOკაზუმასა კობაიაში
Employees3,73 ათ.
Founded22 აგვ. 1919
Headquarters-
SectorPersonal care products
Websitekobayashi.co.jp
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
37,08 მლრდ. / 37,51 მლრდ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
43,02 მლრდ.
53,70 მლრდ.
35,38 მლრდ.
37,08 მლრდ.
Cost of goods sold
20,30 მლრდ.
27,85 მლრდ.
17,21 მლრდ.
18,19 მლრდ.
Cost of revenue
20,30 მლრდ.
27,85 მლრდ.
17,21 მლრდ.
18,19 მლრდ.
Research and development expenses
-
9,12 მლრდ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,87 მლრდ.
6,76 მლრდ.
17,10 მლრდ.
18,08 მლრდ.
Operating expense
17,87 მლრდ.
22,50 მლრდ.
17,10 მლრდ.
18,04 მლრდ.
Total operating expenses
38,17 მლრდ.
50,36 მლრდ.
34,31 მლრდ.
36,23 მლრდ.
Operating income
4,85 მლრდ.
3,35 მლრდ.
1,06 მლრდ.
851,00 მლნ.
Other non operating income
593,00 მლნ.
-150,00 მლნ.
-530,00 მლნ.
20,00 მლნ.
EBT including unusual items
5,02 მლრდ.
-5,52 მლრდ.
1,11 მლრდ.
483,00 მლნ.
EBT excluding unusual items
5,68 მლრდ.
4,07 მლრდ.
829,50 მლნ.
1,33 მლრდ.
Income tax expense
1,37 მლრდ.
-2,37 მლრდ.
541,00 მლნ.
383,00 მლნ.
Effective tax rate
27,33%
42,97%
48,76%
79,30%
Other operating expenses
-
1,26 მლრდ.
-
-
Net income
3,64 მლრდ.
-3,15 მლრდ.
568,00 მლნ.
100,00 მლნ.
Net profit margin
8,47%
-5,87%
1,61%
0,27%
Earnings per share
-
-
-
-
Interest and investment income
94,00 მლნ.
448,00 მლნ.
295,50 მლნ.
454,00 მლნ.
Interest expense
-3,00 მლნ.
-13,00 მლნ.
-5,00 მლნ.
-6,00 მლნ.
Net interest expenses
91,00 მლნ.
435,00 მლნ.
290,50 მლნ.
448,00 მლნ.
Depreciation and amortization charges
-
3,89 მლრდ.
-
-
EBITDA
6,85 მლრდ.
5,53 მლრდ.
3,45 მლრდ.
3,24 მლრდ.
Gain or loss from assets sale
-
-
39,50 მლნ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები